The philadelphia chromosome and chronic myelogenous leukemia

J. H. Tjio, Paul P. Carbone, Jacqueline Whang, Emil Frei

Research output: Contribution to journalArticle

54 Citations (Scopus)

Abstract

Sixty of 73 consecutive patients with clinical and laboratory features of chronic myelogenous leukemia had the Philadelphia (Ph1) chromosome abnormality, as revealed by bone marrow and peripheral blood studies of chromosome morphology. The 13 Ph1-negative patients differed from the larger Ph1-positive group by having lower white blood cell and platelet counts and by having a larger proportion of young children under the age of 7. However, the most significant difference was the finding that the Ph1-negative patients responded poorly to chemotherapy and had a median survival of 18 months as compared to 45 months for the Ph1-positive population (P < 0.01). The Ph1 chromosome was observed during all phases of the disease and was unaffected by treatment. In addition to the Ph1 chromosome, aneuploidy, manifested usually by hyperdiploid Ph1-positive cell lines, was present in 20 percent of the patients. In 2 patients, 2 Ph1 chromosomes were seen in the same cell. A single patient with marked aneuploidy had the only chromosome abnormality seen in the 13 Ph1-negative patients.

Original languageEnglish
Pages (from-to)567-584
Number of pages18
JournalJournal of the National Cancer Institute
Volume36
Issue number4
DOIs
Publication statusPublished - Jan 1 1966
Externally publishedYes

Fingerprint

Philadelphia Chromosome
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Aneuploidy
Chromosome Aberrations
Polyploidy
Platelet Count
Leukocyte Count
Chromosomes
Bone Marrow
Drug Therapy
Cell Line
Survival
Population

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

The philadelphia chromosome and chronic myelogenous leukemia. / Tjio, J. H.; Carbone, Paul P.; Whang, Jacqueline; Frei, Emil.

In: Journal of the National Cancer Institute, Vol. 36, No. 4, 01.01.1966, p. 567-584.

Research output: Contribution to journalArticle

Tjio, J. H. ; Carbone, Paul P. ; Whang, Jacqueline ; Frei, Emil. / The philadelphia chromosome and chronic myelogenous leukemia. In: Journal of the National Cancer Institute. 1966 ; Vol. 36, No. 4. pp. 567-584.
@article{9860f31f10734bd1ab6919304fe9a89b,
title = "The philadelphia chromosome and chronic myelogenous leukemia",
abstract = "Sixty of 73 consecutive patients with clinical and laboratory features of chronic myelogenous leukemia had the Philadelphia (Ph1) chromosome abnormality, as revealed by bone marrow and peripheral blood studies of chromosome morphology. The 13 Ph1-negative patients differed from the larger Ph1-positive group by having lower white blood cell and platelet counts and by having a larger proportion of young children under the age of 7. However, the most significant difference was the finding that the Ph1-negative patients responded poorly to chemotherapy and had a median survival of 18 months as compared to 45 months for the Ph1-positive population (P < 0.01). The Ph1 chromosome was observed during all phases of the disease and was unaffected by treatment. In addition to the Ph1 chromosome, aneuploidy, manifested usually by hyperdiploid Ph1-positive cell lines, was present in 20 percent of the patients. In 2 patients, 2 Ph1 chromosomes were seen in the same cell. A single patient with marked aneuploidy had the only chromosome abnormality seen in the 13 Ph1-negative patients.",
author = "Tjio, {J. H.} and Carbone, {Paul P.} and Jacqueline Whang and Emil Frei",
year = "1966",
month = "1",
day = "1",
doi = "10.1093/jnci/36.4.567",
language = "English",
volume = "36",
pages = "567--584",
journal = "Journal of the National Cancer Institute",
issn = "0027-8874",
publisher = "Oxford University Press",
number = "4",

}

TY - JOUR

T1 - The philadelphia chromosome and chronic myelogenous leukemia

AU - Tjio, J. H.

AU - Carbone, Paul P.

AU - Whang, Jacqueline

AU - Frei, Emil

PY - 1966/1/1

Y1 - 1966/1/1

N2 - Sixty of 73 consecutive patients with clinical and laboratory features of chronic myelogenous leukemia had the Philadelphia (Ph1) chromosome abnormality, as revealed by bone marrow and peripheral blood studies of chromosome morphology. The 13 Ph1-negative patients differed from the larger Ph1-positive group by having lower white blood cell and platelet counts and by having a larger proportion of young children under the age of 7. However, the most significant difference was the finding that the Ph1-negative patients responded poorly to chemotherapy and had a median survival of 18 months as compared to 45 months for the Ph1-positive population (P < 0.01). The Ph1 chromosome was observed during all phases of the disease and was unaffected by treatment. In addition to the Ph1 chromosome, aneuploidy, manifested usually by hyperdiploid Ph1-positive cell lines, was present in 20 percent of the patients. In 2 patients, 2 Ph1 chromosomes were seen in the same cell. A single patient with marked aneuploidy had the only chromosome abnormality seen in the 13 Ph1-negative patients.

AB - Sixty of 73 consecutive patients with clinical and laboratory features of chronic myelogenous leukemia had the Philadelphia (Ph1) chromosome abnormality, as revealed by bone marrow and peripheral blood studies of chromosome morphology. The 13 Ph1-negative patients differed from the larger Ph1-positive group by having lower white blood cell and platelet counts and by having a larger proportion of young children under the age of 7. However, the most significant difference was the finding that the Ph1-negative patients responded poorly to chemotherapy and had a median survival of 18 months as compared to 45 months for the Ph1-positive population (P < 0.01). The Ph1 chromosome was observed during all phases of the disease and was unaffected by treatment. In addition to the Ph1 chromosome, aneuploidy, manifested usually by hyperdiploid Ph1-positive cell lines, was present in 20 percent of the patients. In 2 patients, 2 Ph1 chromosomes were seen in the same cell. A single patient with marked aneuploidy had the only chromosome abnormality seen in the 13 Ph1-negative patients.

UR - http://www.scopus.com/inward/record.url?scp=0013901145&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0013901145&partnerID=8YFLogxK

U2 - 10.1093/jnci/36.4.567

DO - 10.1093/jnci/36.4.567

M3 - Article

VL - 36

SP - 567

EP - 584

JO - Journal of the National Cancer Institute

JF - Journal of the National Cancer Institute

SN - 0027-8874

IS - 4

ER -